Bright Minds Stock Target Price and Analyst Consensus

DRUG Stock  USD 43.96  1.83  4.34%   
The current analyst and expert consensus on Bright Minds is Strong Buy, with 4 strong buy opinions. The current projected Bright Minds target price consensus is 93.76 with 6 analyst opinions. Check out Macroaxis Advice on Bright Minds to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
The most common way Bright Minds Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Bright Minds executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Bright Minds. We strongly encourage you to use your own analysis of Bright Minds Biosciences to validate this buy or sell advice. Bright Minds buy-or-sell recommendation module provides average expert sentiment on the projected Bright Minds Biosciences target price to derive its highest and lowest estimates based on projected price volatility of 4.5008.
Lowest Forecast
85.33
Highest Forecast
104.08
Target Price
93.76
The Bright Minds' current Gross Profit is estimated to increase to about (61.9 K). At this time, Bright Minds' Total Stockholder Equity is most likely to increase significantly in the upcoming years. The Bright Minds' current Accounts Payable is estimated to increase to about 478.1 K, while Net Tangible Assets are projected to decrease to roughly 8.4 M.
It's important to approach Bright Minds' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Bright Minds Target Price Consensus

Bright target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Bright Minds' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   6  Strong Buy
Most Bright analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Bright stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Bright Minds Biosciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Bright Minds Target Price Projection

Bright Minds' current and average target prices are 43.96 and 93.76, respectively. The current price of Bright Minds is the price at which Bright Minds Biosciences is currently trading. On the other hand, Bright Minds' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Bright Minds Market Quote on 25th of August 2025

Low Price42.21Odds
High Price44.25Odds

43.96

Target Price

Analyst Consensus On Bright Minds Target Price

Low Estimate85.33Odds
High Estimate104.08Odds

93.7649

Historical Lowest Forecast  85.33 Target Price  93.76 Highest Forecast  104.08
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Bright Minds Biosciences and the information provided on this page.

Bright Minds Analyst Ratings

Bright Minds' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Bright Minds stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Bright Minds' financials, market performance, and future outlook by experienced professionals. Bright Minds' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Bright Minds price targets

Bright Minds' stock target price is an estimate of its future price, usually made by analysts. Using Bright Minds' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Bright Minds' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Bright Minds' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Bright Minds Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Bright Minds is a key component of Bright Minds valuation and have some predictive power on the future returns of a Bright Minds.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bright Minds' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
38.4542.9547.45
Details
Intrinsic
Valuation
LowRealHigh
39.5655.1759.67
Details
Naive
Forecast
LowNextHigh
38.7743.2747.77
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.67-0.61-0.51
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Driverless Cars Idea
Driverless Cars
Invested few shares
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Banking Idea
Banking
Invested over 30 shares
FinTech Idea
FinTech
Invested over 60 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Momentum Idea
Momentum
Invested few shares
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:
Check out Macroaxis Advice on Bright Minds to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.